欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
HU/H/0761/001
药品名称
Cilostazol 100mg tablets
活性成分
cilostazol 100.0 mg
剂型
Tablet
上市许可持有人
Teva Pharma B.V. Swensweg 5, 2031 GA Haarlem, The Netherlands
参考成员国 - 产品名称
Hungary (HU)
互认成员国 - 产品名称
许可日期
2013/09/06
最近更新日期
2024/02/15
药物ATC编码
B01AC23 cilostazol
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
common - spc
Date of last change:2019/10/07
PAR
|
PAR_MA715_03701
Date of last change:2018/05/08
Final Product Information
|
common label MT_H_0159_001_R_001 TC
Date of last change:2018/05/04
Final Product Information
|
common PIL MT_H_0159_001_R_00 TC
Date of last change:2018/05/04
Final Product Information
|
spc_en_common_Final_CL
Date of last change:2018/05/04
Final Product Information
|
lab_en_common_Final_CL
Date of last change:2018/05/04
Final Product Information
|
common SPC MT_H_0159_001_R_001 TC
Date of last change:2018/05/04
Final Product Information
|
pl_en_common_Final_CL
Date of last change:2018/05/04
Final PL
|
PL71503701
Date of last change:2014/03/14
Final Labelling
|
MT_H_159_160_161_162_163_001_D210-Labelling-100mg
Date of last change:2013/10/02
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase